CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.51%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$733M
Cap. Flow
% of AUM
9.75%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
870
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| 1 |
Amgen
AMGN
|
$78.9M |
| 2 |
Biogen
BIIB
|
$72.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$63.8M |
| 4 |
Merck
MRK
|
$58M |
| 5 |
Gilead Sciences
GILD
|
$33.8M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$26.1M |
| 2 |
iRobot
IRBT
|
$15.5M |
| 3 |
Quest Diagnostics
DGX
|
$15.1M |
| 4 |
Colgate-Palmolive
CL
|
$14.9M |
| 5 |
Philip Morris
PM
|
$12.2M |
Sector Composition
| 1 | Healthcare | 33.27% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RARX
226
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $7.87M | 0.1% |
435,000
+285,000
| +190% | +$5.16M |
|
227
CF Industries
CF
$13.7B
| $7.8M | 0.1% |
143,200
-40,213
| -22% | -$2.19M |
|
228
Citizens Financial Group
CFG
$22.3B
| $7.76M | 0.1% |
201,071
+2,362
| +1% | +$91.1K |
|
229
Ambarella
AMBA
$3.54B
| $7.73M | 0.1% |
199,705
+8,761
| +5% | +$339K |
|
|
CA
230
DELISTED
CA, Inc.
CA
| $7.7M | 0.1% |
174,438
+133,126
| +322% | +$5.88M |
|
|
231
Philip Morris
PM
$251B
| $7.69M | 0.1% |
94,278
-150,200
| -61% | -$12.2M |
|
232
VF Corp
VFC
$5.86B
| $7.66M | 0.1% |
87,040
+43,449
| +100% | +$3.82M |
|
233
MacroGenics
MGNX
$126M
| $7.65M | 0.1% |
356,600
+265,000
| +289% | +$5.68M |
|
234
Weibo
WB
$2.87B
| $7.53M | 0.1% |
103,000
-135,600
| -57% | -$9.92M |
|
235
Zions Bancorporation
ZION
$8.34B
| $7.5M | 0.1% |
149,597
-33,174
| -18% | -$1.66M |
|
|
MITL
236
DELISTED
Mitel Networks Corporation
MITL
| $7.48M | 0.1% |
+678,470
| New | +$7.48M |
|
237
EQT Corp
EQT
$32.2B
| $7.47M | 0.1% |
310,166
+74,512
| +32% | +$1.79M |
|
238
Kellanova
K
$27.8B
| $7.46M | 0.1% |
113,393
-30,832
| -21% | -$2.03M |
|
239
Jefferies Financial Group
JEF
$13.1B
| $7.42M | 0.1% |
+377,291
| New | +$7.42M |
|
240
Costco
COST
$427B
| $7.38M | 0.1% |
31,428
+70
| +0.2% | +$16.4K |
|
241
Target
TGT
$42.3B
| $7.35M | 0.1% |
83,325
-6,106
| -7% | -$539K |
|
242
Itaú Unibanco
ITUB
$76.6B
| $7.32M | 0.1% |
1,333,916
| – | – |
|
|
WBA
243
DELISTED
Walgreens Boots Alliance
WBA
| $7.31M | 0.1% |
100,327
+10,110
| +11% | +$737K |
|
244
US Bancorp
USB
$75.9B
| $7.29M | 0.1% |
138,106
-81,860
| -37% | -$4.32M |
|
|
COL
245
DELISTED
Rockwell Collins
COL
| $7.29M | 0.1% |
51,894
+29,089
| +128% | +$4.09M |
|
246
Rigel Pharmaceuticals
RIGL
$742M
| $7.28M | 0.1% |
226,800
+69,800
| +44% | +$2.24M |
|
247
CytomX Therapeutics
CTMX
$376M
| $7.27M | 0.1% |
392,727
+212,600
| +118% | +$3.93M |
|
|
APC
248
DELISTED
Anadarko Petroleum
APC
| $7.17M | 0.1% |
106,355
+7,459
| +8% | +$503K |
|
|
XLRN
249
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.15M | 0.1% |
125,000
+28,000
| +29% | +$1.6M |
|
250
Altria Group
MO
$112B
| $7.15M | 0.1% |
118,595
-156,081
| -57% | -$9.41M |
|